LAS VEGAS, March 18, 2025 /PRNewswire/ — ClinCapture, a leader in clinical trial management solutions, is excited to announce the launch of two groundbreaking feature enhancements designed to streamline study documentation and audit processes for clinical research organizations worldwide.
Revolutionizing Document Management with eTMF Capabilities
The newly integrated eTMF (electronic Trial Master File) functionality offers robust tools to:
“Our new eTMF capabilities are designed to provide researchers with a seamless and secure document management experience,” said Scott Weidley, CEO at ClinCapture. “By centralizing study and site documentation and offering granular permission controls, we empower our users to manage their documents exactly their way.”
Streamlining Audit Processes with Enhanced Subject Audit Log Export
In addition to powerful document management, ClinCapture now introduces the Enhanced Subject Audit Log Export feature, allowing users to:
“The Enhanced Subject Audit Log Export feature is a game-changer for our users,” said Amanda McLean, VP of Sales and Customer Enablement. “By simplifying the audit process and clinical research teams can now focus more on analysis and decision-making rather than administrative tasks.”
Key Benefits for Users
ClinCapture’s commitment to innovation in clinical research is underscored by these new feature releases designed to support efficient study management and robust data analysis. For more information about these new features or to schedule a product demo, please visit ClinCapture.com or contact our press team at jacob.roach@clincapture.com.
About ClinCapture
ClinCapture is a leading provider of clinical trial management solutions, dedicated to empowering research teams with secure, innovative, and effective tools. With a focus on enhancing productivity and ensuring compliance, ClinCapture continues to set the standard in clinical research technology.
SOURCE ClinCapture, Inc.
- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page…
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing…
PLEASANTON, Calif., May 16, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology,…
YPSILANTI, Mich., May 16, 2025 /PRNewswire/ -- Eastern Michigan University is revolutionizing health education for…
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 16, 2025…
Adam Kovalčík, 19, receives $100,000 Top Award for his development of a medicine that can…